SLC2A12 and ovarian cancer: In ovarian cancer models, hypoxia induces HIF-1α to upregulate solute carrier family 2 member 12 (SLC2A12), engaging glutathione metabolism, inhibiting ferroptosis, and promoting tumor progression and drug resistance [88].